abstract |
The present invention relates to compounds of formula (I) and (II) and solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof which inhibit protein tyrosine kinases, in particular c-fms kinase: R in (I), (II) 1 , R 2 , R 3 , R 5 , R 6 , Y 1 , Y 2 , Y 3 , Y 4 and X are defined in the detailed description. |